This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Characterizing novel hippocampal drugs for Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Mechanism of IL-1 Dependent A-beta Plaque Clearance in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Novel Drug Discovery for AD Targeting Ryanodine Calcium Channels Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Amyloid ion channels to design therapeutics for neurodegenerative diseases Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Nomethiazoles harnessing GABA and NO mimetic activity for Alzheimers therapy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
SMALL MOLECULE THERAPY FOR ALZHEIMERS DISEASE Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
LISPRO, an ionic cocrystal of lithium, as a potential novel treatment for Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Plasticity circuits in Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Development of EP2 receptor antagonists for suppression of Alzheimers neuropathology Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
